BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 60682)

  • 21. Carcinoembryonic antigen in chronic otitis media: an immunohistochemical study of the middle ear mucosa.
    Sankovic S; Sofronic L
    Acta Otorhinolaryngol Belg; 2002; 56(1):61-4. PubMed ID: 11894632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The inhibition of various bacterial proteinases with natural proteinase inhibitiors(author's transl)].
    Theopold HM; Hochstrasser K; Baurnfeind A; Wunderlich H
    Laryngol Rhinol Otol (Stuttg); 1975 Jan; 54(1):14-8. PubMed ID: 123295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canal-down tympanoplasty; one-stage tympanoplasty with mastoid obliteration, for non-cholesteatomatous chronic otitis media associated with osteitis.
    Shinkawa A; Sakai M; Tamura Y; Takahashi H; Ishida K
    Tokai J Exp Clin Med; 1998 Mar; 23(1):19-23. PubMed ID: 9972532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of chronic otitis media in the only hearing ear.
    Battaglia AS; Sabri AN; Jackson CG
    Laryngoscope; 2002 Apr; 112(4):681-5. PubMed ID: 12150523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ofloxacin in the treatment of Pseudomonas aeruginosa infections of the ear].
    Oberascher G; Karas C
    HNO; 1988 Jun; 36(6):230-3. PubMed ID: 3165974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal biofilm formation on middle-ear mucosa in a nonhuman primate model of chronic suppurative otitis media.
    Dohar JE; Hebda PA; Veeh R; Awad M; Costerton JW; Hayes J; Ehrlich GD
    Laryngoscope; 2005 Aug; 115(8):1469-72. PubMed ID: 16094127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteolytic activity of selected clinical isolates of Serratia marcescens against human serum proteins.
    Doerr M; Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):196-207. PubMed ID: 6181630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surgical therapy of Pseudomonas aeruginosa infections in chronic otitis media].
    Weichselbaumer W
    Monatsschr Ohrenheilkd Laryngorhinol; 1971; 105(3):112-20. PubMed ID: 5001389
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental otitis media in chinchillas. I. Baseline immunological investigation.
    Watanabe N; Briggs BR; Lim DJ
    Ann Otol Rhinol Laryngol Suppl; 1982; 93():1-8. PubMed ID: 6807183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibitors of proteolytic enzymes in the blood serum of patients with diphyllobothriasis].
    Gosteva LA
    Med Parazitol (Mosk); 1990; (4):29-31. PubMed ID: 1700263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.
    Wright A; Hawkins CH; Anggård EE; Harper DR
    Clin Otolaryngol; 2009 Aug; 34(4):349-57. PubMed ID: 19673983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental otitis media in chinchillas. II. Comparison of the middle ear immune responses to S pneumoniae types 3 and 23.
    Watanabe N; DeMaria TF; Lewis DM; Mogi G; Lim DJ
    Ann Otol Rhinol Laryngol Suppl; 1982; 93():9-16. PubMed ID: 6807184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Character of changes in protease inhibitory capacity of blood in experimental osteoarticular tuberculosis].
    Titarenko OT; Esmedliaeva DS; Nakonechnyĭ GD; Momot DS; Perova TL
    Vopr Med Khim; 1992; 38(1):16-8. PubMed ID: 1279893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis and treatment of chronic purulent otitis media and its complications: immunological aspects].
    Talyshinskiĭ AM; Garaev AR
    Vestn Otorinolaringol; 2001; (3):18-22. PubMed ID: 11510039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemagglutination reactions of tanned red cells with Pseudomonas aeruginosa extract as the antigen--preliminary observation on the serum of patients with chronic otitis media].
    Takai A; Nagao S; Mori H
    Nihon Saikingaku Zasshi; 1971 Oct; 26(10):467-72. PubMed ID: 5004653
    [No Abstract]   [Full Text] [Related]  

  • 36. Protease inhibitors in middle ear effusions.
    Carlsson B; Lundberg C; Ohlsson K
    Ann Otol Rhinol Laryngol; 1981; 90(1 Pt 1):38-41. PubMed ID: 6162410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological aspects of secretory otitis media in Iranian children, immunoglobulin and complement concentration in serum and glue.
    Amirzargar A; Feghhi S; Nicknam MH; Saki N
    Iran J Allergy Asthma Immunol; 2003 Mar; 2(1):25-30. PubMed ID: 17301353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Boyden reaction using Pseudomonas aeruginosa extract from chronic tympanitis otorrhea as antigen].
    Mri H; Nagao S; Takai A
    Nihon Saikingaku Zasshi; 1970 Sep; 25(9):415-6. PubMed ID: 4993137
    [No Abstract]   [Full Text] [Related]  

  • 39. [In vitro experiments on extracellular proteolytic activity of Pseudomonas aeruginosa in connection with phytopathological studies].
    Knösel D; Nimitan E
    Z Allg Mikrobiol; 1976; 16(8):609-14. PubMed ID: 12623
    [No Abstract]   [Full Text] [Related]  

  • 40. Proteases and protease inhibitors in immune complex otitis media in chinchillas.
    Hamaguchi Y; Juhn SK; Morizono T; Sakakura Y
    Ann Otol Rhinol Laryngol; 1989 Jul; 98(7 Pt 1):563-8. PubMed ID: 2473673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.